Detection of beta-human chorionic gonadotropin expressing cells by nested reverse transcriptase-polymerase chain reaction in the peripheral blood stem cells of patients with advanced germ cell tumor.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11832775.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We investigated whether peripheral blood stem cells (PBSCs) were contaminated by tumor cells. A total of 13 patients with advanced testicular cancer underwent PBSC transplantation at our institute. Nested reverse transcriptase-polymerase chain reaction using primers specific for beta-human chorionic gonadotropin (beta-HCG) or alpha-fetoprotein (AFP) detected 1 beta-HCG or AFP producing cell in 1 x 10(6) PBSCs. Although AFP messenger (m) RNA was not identified in any of the 13 patients, beta-HCG mRNA was detected in 7. All patients with beta-HCG mRNA in PBSCs had elevated serum beta-HCG before treatment. Three patients with a normal beta-HCG range before treatment did not have beta-HCG mRNA in the PBSCs. The serum beta-HCG level in the patients whose PBSCs were contaminated with tumor cells was significantly higher than in patients whose PBSCs contained no tumor cells. Four of the 7 patients with beta-HCG mRNA in PBSCs eventually died of cancer, whereas those whose PBSCs were not contaminated with tumor cells survived without disease. Patients with elevated serum beta-HCG levels are likely to have PBSCs contaminated by tumor cells. Moreover, the prognosis of patients with tumor cells in the PBSCs is poor.
Medical subject headings
- Chorionic Gonadotropin, beta Subunit, Human
- Germinoma
- Leukocytes, Mononuclear
- Reverse Transcriptase Polymerase Chain Reaction
- Testicular Neoplasms